Orientation & Understanding Your Diagnosis

Receiving a diagnosis of intermediate uveitis can be overwhelming, especially when it involves your vision. It is natural to feel anxious about the future of your sight. However, for most people, the long-term outlook for vision is favorable when inflammation and its complications are closely monitored and controlled ^[1][2].

Intermediate uveitis is a form of eye inflammation that primarily affects the middle part of the eye. While it can occur at any age, including in children and adolescents, it is considered a relatively rare condition ^[3][4]. Because it often develops slowly, the goal of your medical team is to identify the cause, control the inflammation, and prevent damage to the parts of the eye responsible for clear vision.

What is Intermediate Uveitis?

Intermediate uveitis is a medical term used to describe inflammation that is centered in the vitreous (the clear, jelly-like fluid that fills the eye), the pars plana (a narrow area near the front of the eye), and the peripheral retinal blood vessels ^[3].

Unlike other types of uveitis that might cause a very red or painful eye, intermediate uveitis often starts with painless “floaters” or a gradual blurring of vision. Because the inflammation is “intermediate” (in the middle), your doctor will use specialized tools like a dilated eye exam and Optical Coherence Tomography (OCT)—a high-definition scan of the retina—to see what is happening deep inside the eye.

Understanding the Subtypes

Your doctor will try to determine if your inflammation is “idiopathic” (meaning it happens on its own) or if it is a sign of an underlying systemic condition.

Pars Planitis

This is a specific subset of intermediate uveitis where no other cause or associated disease can be found ^[5][6]. It is often characterized by two unique findings:

• Snowballs: Small, white clumps of inflammatory cells floating in the vitreous ^[5].
• Snowbanks: Larger, thicker deposits of white inflammatory material that settle over the pars plana area ^[5].

Pars planitis is particularly common in children and young adults, accounting for a significant portion of pediatric uveitis cases ^[6][7].

Associated Systemic Conditions

In some cases, intermediate uveitis is the first sign of a condition affecting the rest of the body. Common associations include:

• Sarcoidosis: An inflammatory disease that can affect multiple organs, including the lungs and lymph nodes ^[8][9].
• Multiple Sclerosis (MS): A condition affecting the central nervous system. Intermediate uveitis with inflammation of the retinal blood vessels (vasculitis) can sometimes occur alongside MS ^[10][11].
• Infections: Infections like syphilis, tuberculosis, or Lyme disease can sometimes present as or “mimic” intermediate uveitis ^[12][13].

Masquerade Syndromes

In older adults, doctors must occasionally rule out “masquerade” conditions that look like inflammation but are actually caused by something else, such as Primary Vitreoretinal Lymphoma (a rare type of cancer). Identifying these early is crucial for starting the correct treatment ^[14][15].

Vision and Long-Term Outlook

The prognosis for vision in intermediate uveitis is generally positive. In many studies, a majority of patients maintained stable, useful vision over 5 to 10 years of follow-up ^[1]. However, long-term results can differ substantially depending on the exact cause, whether the disease affects one or both eyes, and how the eye responds to treatment.

The “threat” to vision usually comes from secondary complications rather than the inflammation itself. The most common complication is Cystoid Macular Edema (CME)—swelling in the central part of the retina (the macula) ^[1][16]. If CME is left untreated, it can lead to permanent vision loss. Other potential complications include:

• Cataracts: Clouding of the eye’s natural lens, which can result from both the inflammation and long-term steroid treatment ^[17].
• Glaucoma: Increased pressure inside the eye, which requires careful monitoring to prevent damage to the optic nerve ^[18][19].

The Road Ahead

Managing intermediate uveitis is a marathon, not a sprint. Your care team may use a combination of treatments. It is important to know that while topical eye drops may be used for surface discomfort, anterior inflammation, or eye pressure, they generally do not reach deep enough to treat intermediate inflammation. Instead, doctors use periocular (around the eye) injections, intravitreal implants, or systemic (oral) medications to manage the deep inflammation and keep the eye healthy.

By staying consistent with your exams and reporting any new floaters or blurriness immediately, you play a vital role in protecting your sight. For more information on managing complications, see the “Complications & Structural Monitoring” section.